NEW YORK (GenomeWeb News) – Pfizer Animal Health said this week that it will acquire two livestock genomics companies, Catapult Genetics and Bovigen, for an undisclosed sum.
 
Catapult develops and sells livestock DNA tests and gene markers and was formed through the 2006 merger of New Zealand’s Catapult Systems with Australia’s Genetic Solutions. Harahan, La.-based Bovigen is a livestock genetic test developer and distributor whose customers include Catapult.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.